The Open University
Adhesion G protein-coupled receptor Gpr126 as a drug target for ischemic stroke
Abstract
dc:description.abstractThe development of the central nervous system, angiogenesis, and blood-brain barrier maturation is controlled by intricate signaling pathways, with Wnt signaling playing a pivotal role. This study examines the role of adhesion G-protein coupled receptor Gpr126 in regulating BBB formation and its involvement in ischemic stroke. Gpr126 was shown to be regulated by the Wnt/β-catenin pathway specifically in brain endothelial cells, influencing both BBB development and vascular integrity. Gpr126 expression was found across several brain regions, where it plays a region-specific role in BBB maturation. Electron microscopy revealed Gpr126 localization at endothelial membranes, pericytes, and endosomes, implicating its involvement in intracellular signaling and receptor recycling. The absence of Gpr126 resulted in abnormal vascular architecture, including enlarged vessels and reduced vascular density, particularly in the cortex and striatum. This dysfunction reduced endothelial cell thinning, leading to increased transcellular permeability through dynamin-dependent endocytosis, rather than disruption of paracellular junctions. Additionally, Gpr126-deficient cells exhibited impaired β1-integrin internalization, which reduced angiogenic sprout formation and elongation, essential for proper BBB development. While no significant vascular abnormalities were observed in adult Gpr126-deficient mice, however, in a model of mouse ischemic stroke, Gpr126 deficiency reduced brain lesion volume and attenuated microglial activation. These effects were linked to the role of Gpr126 in regulating NF-κB signaling and inflammatory pathways. Gpr126-deficient ECs showed reduced expression of proinflammatory cytokines and an increase in anti-inflammatory markers during reperfusion. Collectively, these findings underscore the dual role of Gpr126 in BBB development and stroke pathology, positioning it as a potential therapeutic target for ischemic stroke.
Degree
thesis:*- Name dc:type.qualificationname
- phd
- Level dc:type.qualificationlevel
- doctoral
- Grantor dc:publisher.institution
- The Open University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Scalise, Anna
Rights
- Language dc:language
- en